Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron

J Infect. 2024 Jun;88(6):106165. doi: 10.1016/j.jinf.2024.106165. Epub 2024 Apr 24.

Affiliations

¹ ALZAK Foundation, Cartagena, Colombia; Universidad del Sinu, Cartagena, Colombia.
² Secretary of Health, Bogota, Colombia.
³ ALZAK Foundation, Cartagena, Colombia; Universidad de Cartagena, Cartagena, Colombia.
⁴ ALZAK Foundation, Cartagena, Colombia.
⁵ Universidad Nacional de Colombia, Bogotá, Colombia.
⁶ University of Oxford, Oxford, UK.
⁷ Universidad Nacional de Colombia, Bogotá, Colombia. Electronic address: fpdelahozr@unal.edu.co.

PMID: 38670269
DOI: 10.1016/j.jinf.2024.106165

No abstract available

Publication types

Letter

MeSH terms

Adult
Antibodies, Neutralizing / blood
Antibodies, Neutralizing / immunology
Antibodies, Viral / blood
BNT162 Vaccine* / administration & dosage
COVID-19 Vaccines* / immunology
COVID-19* / virology
Humans
Immunization, Secondary*
SARS-CoV-2* / genetics

Supplementary concepts

SARS-CoV-2 variants